Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 10Small Cell Lung Carcinoma 6Thymoma 5Carcinoma, Renal Cell 4Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Thyroid Neoplasms 2Stomach Neoplasms 2Prostatic Neoplasms 2Gastrointestinal Stromal Tumors 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thoracic Neoplasms 1Somatostatinoma 1Recurrence 1Rectal Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Nervous System Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma, Malignant 1Mesothelioma 1Melanoma 1Lymphoma 1

Interventions

pembrolizumab 3Quality of Life 2Proton Therapy 2Immunotherapy 2Drug Therapy 2fludarabine 1epacadostat 1bosutinib 1amrubicin 1alovudine 1Tumor Burden 1Sunitinib 1Radiotherapy 1Radiosurgery 1Radiation 1Plicamycin 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Histocompatibility Testing 1Erlotinib Hydrochloride 1Cyclophosphamide 1Blood Specimen Collection 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymus Neoplasms × Sunitinib × Thoracic × Clear all
NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
56 enrolled 15 charts
Thoracic

Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡